421 results about "Prognosis prediction" patented technology

The invention discloses a brain tumor multi-mode large model construction method, device and equipment and a storage medium, and is applied to the technical field of brain tumor imagines.The method comprises the steps that pixel-concept level alignment is conducted on a multi-mode MRI image and a pathological text; constructing a multi-modal feature fusion network for fusing image features and text features by adopting an attention mechanism of pathology perception and combining medical semantic information; training the multi-modal feature fusion network to generate an analysis report and a segmentation result; according to the technical scheme of multi-task cooperation, cross-modal pathological semantic accurate alignment, pathological knowledge graph injection and lightweight and continuous optimization parallelization, full-process coverage of brain tumor accurate segmentation, analysis report generation and prognosis prediction is achieved, the problems that a traditional model lacks pathological semantic support and is insufficient in clinical adaptability are solved, and the clinical adaptability of the traditional model is improved. And the deployment feasibility and the dynamic optimization capability are also considered.

The invention relates to an advanced gastric cancer survival prediction system based on Lasso regression, Cox regression and an interpretable machine learning technology, and belongs to the technical field of medical artificial intelligence and intelligent decision support. According to the system, by collecting multi-modal clinical data (including demographic information, TNM staging, treatment modes, tumor grading and the like) of a patient, survival-related variables are screened by adopting Lasso regression and a Cox proportional risk model, and an optimized feature set is constructed. Based on the feature set, the system integrates various mainstream machine learning algorithms (such as XGBoost, Random Forest, SVM, Logistic regression and the like) to construct a prediction model, compares the performance of each model, and selects a model with an optimal effect as a main model. And hyper-parameter tuning is performed on the model through grid search and cross validation, so that the precision and generalization ability of the model are improved. An SHAP interpretability analysis method is introduced into the system, transparent interpretation is carried out on a model output result from the global level and the individual level, and the importance and directional effect of all variables in survival prediction are determined. Finally, the model is deployed on a terminal device, a doctor is supported to automatically output the survival probability and an explanation result after inputting patient information, and a reference basis is provided for clinical treatment decision and personalized management. The system has the advantages of high prediction precision, high interpretability, convenience in use, sustainable optimization and the like, is suitable for clinical aid decision-making scenes, and has good application prospects and popularization values.

The invention discloses a cerebral apoplexy risk and prognosis prediction system and method, and relates to the field of intelligent medical treatment, and the system comprises a data processing and knowledge construction layer which is used for extracting, cleaning and constructing a space-time multi-modal knowledge graph and structured clinical features from multi-source heterogeneous medical data; the feature engineering and fusion layer is used for deeply fusing dynamic semantic information in the space-time multi-modal knowledge graph and the structured clinical features through a graph embedding and attention mechanism to generate a fusion feature vector for a cerebral apoplexy prediction task; and the prediction model and output layer is used for performing cerebral apoplexy risk and prognosis prediction based on the fusion feature vector to obtain a prediction result, and generating a decision result for assisting a doctor in understanding the model through an interpretable mechanism. The method provided by the invention can improve the accuracy of stroke recurrence, bleeding transformation or function prognosis prediction, and provides a new way for accurate stroke management.

The invention discloses a multi-omics causal structure relation learning method based on comparative learning, which comprises the following steps: firstly, respectively constructing corresponding encoders for preprocessed gene mutation and gene expression data, and respectively carrying out feature extraction on two kinds of omics data; then, constructing a projection head with shared parameters to realize cross-modal feature alignment; then, using the aligned features as nodes, and constructing causal graph data through a learnable causal graph structure; constructing a graph neural network to learn causal graph representation, and constructing a contrast loss function; and finally, a model prediction result is obtained through a multi-layer perceptron, a survival prediction loss function is constructed, and a total loss function is obtained for multi-omics causal structure model training. Based on gene mutation and gene expression data, a cross-omics causal structure relationship is constructed and learned through comparative learning, more accurate prognosis prediction is provided for diseases such as acute myelogenous leukemia and the like, and potential biomarkers and key regulatory factors are helped to be found.

A juvenile depression cognitive impairment subtype classification and prognosis prediction method relates to the technical field of medical treatment, and mainly comprises the following steps: performing clinical evaluation and therapeutic response evaluation on a subject, performing MRI and magnetoencephalogram data acquisition, constructing a whole brain MSN of the subject, identifying MSN abnormal characteristics, obtaining functional connection change of a frequency band when magnetoencephalogram is abnormal, and determining the cognitive impairment subtype classification and prognosis prediction of the cognitive impairment subtype of the subject. A subtype classification model is established by fusing the MSN and cognitive function evaluation data, and a prognosis prediction model is established by analyzing MSN abnormal features, functional connection changes of frequency bands during abnormality, multi-dimensional treatment reactions and high-risk behaviors. According to the method, different levels of fusion measurement are carried out on the juvenile depression with cognitive function impairment brain mechanism through multi-modal brain images, a subtype classification model with diagnosis and treatment values is established, and a prognosis prediction model with clinical transformation potential is constructed; therefore, a theoretical basis and a technical means are provided for individualized precise diagnosis and treatment of the cognitive impairment of the juvenile depression.

The invention provides a laryngeal cancer multi-mode prognosis prediction method and a laryngeal cancer multi-mode prognosis prediction system fusing a CT (Computed Tomography) image and a ViT model. Relates to the technical field of biomedical images. The method comprises the following steps: acquiring and preprocessing multi-modal data of a laryngocarcinoma patient; carrying out lightweight compression, redundant information screening and robustness training on the ViT model to obtain an optimized ViT model; extracting depth features of the CT image data based on the optimized ViT model, and performing multi-stage fusion on the depth features and clinical and genome data to construct a prognosis prediction model; and performing risk stratification on the patient according to a prognosis prediction result predicted by the prognosis prediction model, and outputting treatment guidance suggestions based on the risk stratification. Through ViT model optimization, multi-modal data fusion and clinical adaptation design, precise prediction and personalized treatment guidance of laryngocarcinoma prognosis are realized, and the problems of insufficient image degradation processing, low model deployment efficiency and the like in existing laryngocarcinoma prognosis prediction are solved.

The invention discloses a tumor prognosis prediction method and a tumor prognosis prediction system, which are used for constructing a multi-modal fusion model based on image-pathology to improve the prognosis prediction efficiency of tumors, especially pancreatic cancer, and providing reference information for clinical decision-making. According to the technical scheme, the method comprises the following steps: S1, preprocessing an original tumor enhanced CT image, segmenting a tumor region, extracting radiomics features and depth image features of the tumor region, and establishing a CT image feature set; s2, after feature preprocessing is carried out on the tumor clinical data, clinical features with statistical significance are screened out, and a clinical feature set is established; s3, carrying out Hamp; e, preprocessing the pathological image, segmenting a tissue region, extracting spatial relation features, and generating a pathological spatial feature set; and S4, based on a feature interaction method, carrying out multi-modal fusion on the CT image features, the clinical features and the pathological spatial features, inputting a full-connection neural network, constructing a tumor survival risk prediction model, and outputting a tumor survival risk probability through the tumor survival risk prediction model.

The invention relates to the technical field of rectal cancer prognosis prediction, in particular to a rectal cancer prognosis prediction method and device based on a multi-modal image and electronic equipment. The method comprises the following steps: firstly, acquiring an MRI image and a pathological image of a patient as original input data; respectively preprocessing the MRI image and the pathological image by adopting a double-flow heterogeneous feature extractor; then, by establishing a dynamic association mechanism, the change of the mapping relation between the two kinds of modal feature data is tracked in real time, the dynamic association mechanism can adjust the feature weight in a self-adaptive mode, and key changes in the disease progress process are effectively captured; and finally, based on the obtained dynamic association feature data, applying a pre-trained prediction model to obtain a prognosis prediction result. The MRI image and the pathological image are effectively integrated, and the accuracy of predicting the disease progress and the prediction repeatability are improved.

The invention discloses a lung cancer lifetime prediction system based on prognosis factor multi-data fusion, and belongs to the technical field of lung cancer prognosis prediction, and the system comprises a multi-source data collection module which is used for collecting prognosis multi-source data of a patient; the multi-source data processing module is used for carrying out preprocessing and feature extraction on the prognosis multi-source data of the patient; the multi-source data fusion module is used for carrying out cross-modal alignment and fine-grained fusion on the extracted multi-modal feature vectors, and capturing a dependency relationship between modals based on a hierarchical attention mechanism to form patient prognosis fusion data; and the survival analysis and prediction module is used for analyzing the prognosis fusion data of the patient according to the lung cancer lifetime prediction model, automatically predicting the lifetime of the patient and displaying the lifetime in a visual form. The problems that existing lung cancer lifetime prediction is low in accuracy and cannot provide support for personalized treatment are solved. The lung cancer lifetime prediction accuracy can be improved, and support can be provided for personalized treatment.

The invention discloses a disease prognosis evaluation and dynamic prediction method based on time sequence analysis, which comprises the following steps: acquiring disease prognosis medical data of a patient to construct a medical data time sequence set, extracting medical data time sequence characteristics and constructing a prognosis evaluation model, updating the prognosis evaluation model, and performing dynamic prediction. Inputting the to-be-evaluated patient disease prognosis medical data into the updated prognosis evaluation model to obtain a disease prognosis evaluation result, constructing a prognosis prediction model, inputting the to-be-evaluated patient disease prognosis medical data into the prognosis prediction model to obtain a disease prognosis prediction result, and updating the disease prognosis prediction result. And generating evaluation interpretation, prediction interpretation, a disease prognosis evaluation chart and a disease prediction trend chart. According to the method, the efficiency and accuracy of disease prognosis evaluation and prediction can be improved, timely and effective decision support is provided for clinic, the requirements of personalized medical treatment are met, and more accurate treatment schemes and rehabilitation guidance are provided for patients.

The invention relates to the technical field of pathological section image recognition, in particular to a system for achieving precise prognosis prediction of a gastric cancer patient based on deep learning, and aims at achieving precise prognosis prediction of the gastric cancer cell tumor patient on the pathological section level. The implementation package of the system comprises an information acquisition module, an image processing module, a wavelet parallel Mama model module, a result prediction module and an interpretability module, so that the efficiency of image feature extraction and the accuracy of model prediction are greatly improved. The core target of the invention is to solve the problems of insufficient accuracy, poorer result stability, limited model generalization ability, lack of interpretability and the like in the existing gastric cancer prognosis prediction method. Through strict verification and testing, the wavelet parallel Mama model of the research shows excellent performance in the aspect of predicting the total lifetime of gastric cancer patients in multiple centers, provides reliable support for clinical decision-making, and manifests the huge potential of the wavelet parallel Mama model in application in the field of precision medical treatment.

The invention provides a clustering method and system for transcriptome sequencing data. The method is applied to the technical field of data processing, and comprises the following steps: collecting cervical adenocarcinoma and para-carcinoma tissue specimens of a plurality of patients, and carrying out data preprocessing to obtain a standardized gene expression matrix; performing clustering operation on the standardized gene expression matrix based on a clustering analysis method combining a potential category model and sub-alliance division to obtain a clustered gene set; performing gene function annotation on the clustered gene set, and performing correlation analysis on a clustering result after function annotation and clinical characteristics of cervical adenocarcinoma to obtain correlation between gene expression and the clinical characteristics; and on the basis of clustering analysis and correlation analysis results, constructing a deep clustering prediction model based on a variational auto-encoder and a Gamma hybrid model so as to predict the prognosis risk or chemotherapy sensitivity of the patient. The problems that high-dimensional transcriptome data is poor in clustering stability and low in prognosis prediction precision are solved.

The invention belongs to the technical field of osteosarcoma prognosis prediction, and relates to a multi-view TSK deep learning model based on Dirichlet distribution and application thereof, a multi-view data module in the model transmits view features to a multi-view TSK fuzzy system module, and the multi-view TSK fuzzy system module maps the input view features into Dirichlet evidence parameters and transmits the Dirichlet evidence parameters to a Dirichlet distribution module; the Dirichlet distribution module establishes a classification probability representation space according to Di richlet evidence parameters and transmits the classification probability representation space to the uncertainty quantification module, the uncertainty quantification module quantifies the classification probability into view decision confidence through a dynamic evidence aggregation engine, self-adaptive weighted fusion is carried out on the view decision confidence through a combination rule, and the view decision confidence is obtained. And a multi-view TSK deep learning model is applied to osteosarcoma prognosis prediction, so that the prediction accuracy is improved.

The invention relates to the technical field of bioinformatics analysis, in particular to an enhanced CT image-based hepatocellular carcinoma postoperative early recurrence multi-modal prediction model and a construction method thereof, and the construction method comprises the following steps: S1, data acquisition: collecting clinical data and liver enhanced CT images of a hepatocellular carcinoma surgical patient, and evaluating the recurrence condition of the HCC patient; s2, image preprocessing: sketching a region of interest in the image, and extracting deep learning features; s3, establishing a model: establishing a plurality of image omics models, constructing a plurality of deep learning models, and constructing a multi-modal model; s4, evaluating and verifying the model: evaluating the prediction accuracy of the multi-modal model by adopting an ROC curve and an AUC value, and evaluating the prognosis prediction capability of the patient by using a Kaplan-Meier curve; according to the method, the characteristic expression ability and the recurrence risk discrimination performance are improved, a scientific basis can be provided for follow-up visit and treatment of the hepatocellular carcinoma postoperative patient, and the lifetime of the patient is prolonged.

The invention discloses a multi-mode head and neck tumor segmentation and survival prognosis prediction method. The method comprises the following steps: constructing a DE-LS-UNet model; training the DE-LS-UNet model to obtain a trained DE-LS-UNet model, and inputting the new PET image and the CT image into the trained DE-LS-UNet model to obtain a predicted tumor segmentation mask; extracting multi-modal radiomics features according to the predicted tumor segmentation mask, and fusing clinical features through the multi-modal radiomics features to generate multi-source features of the patient; inputting the multi-source features of the patient into the survival analysis model for training to obtain a trained survival analysis model, and inputting the features of the patient into the trained survival analysis model to obtain a prognosis prediction result. According to the method, a feature extraction and fusion mechanism is provided, and a survival analysis model strategy is combined, so that the stability and prediction performance of survival prognosis modeling can be enhanced while the image segmentation precision is improved.

The invention provides a glycolipid metabolism related gene-based endometrial cancer prognosis prediction model construction method, which comprises the following steps of 1, acquiring data containing gene expression and clinical information, and preprocessing the data; 2, differential expression and prognosis gene screening; 3, constructing a prognosis model; 4, analyzing model gene enrichment; 5, evaluating the immunocompetence of the two GLRG related dangerous groups; and step 6, statistical analysis. According to the technical scheme, more accurate and reliable prognosis evaluation is provided for endometrial cancer by comprehensively analyzing multi-dimensional information such as gene expression, immune characteristics, mutation characteristics and drug sensitivity.

A hybrid liver cancer prognosis model, prognosis system and medium, the model takes independent influence factors as input and outputs hybrid liver cancer postoperative risk scores, the hybrid liver cancer postoperative risk scores are used for dividing risk levels, and the risk levels are used for hybrid liver cancer prognosis evaluation. And / or is used for postoperative adjuvant chemotherapy decision-making of mixed liver cancer. The hybrid liver cancer prognosis model is jointly constructed by combining the traditional clinical pathological characteristics and immune microenvironment indexes, the key effect of the tumor immune microenvironment in CHC prognosis is indicated, and the constructed hybrid liver cancer prognosis model has good CHC prognosis prediction performance; in addition, decisions of postoperative adjuvant chemotherapy can be provided for patients with different risk levels, precise treatment of the CHC patients is achieved, and long-term survival prognosis of the CHC patients is improved.

The invention discloses a bladder cancer muscular layer infiltration and prognosis prediction system based on deep learning imageomics, relates to the technical field of medical treatment and belongs to auxiliary diagnosis, and adopts an imageomics method and a deep learning model to extract imageomics features and deep learning features of CT images respectively; compared with the prior art, potential meaningful features in the CT image are extracted more comprehensively, the prediction accuracy can be further improved, meanwhile, the features are screened more strictly by using technologies such as intra-class correlation coefficient (ICC) analysis, t inspection, Pearson correlation coefficient, minimum absolute contraction and selection operator (LASSO), PCA dimension reduction and Cox regression, and verification is performed in a plurality of external medical centers. On one hand, the over-fitting risk of the model can be greatly reduced, on the other hand, the excellent generalization of the model is also proved, the use of the model is not excessively influenced by the medical environment and the CT acquisition instrument, and the error generated by the multi-center effect can be effectively solved.

The invention discloses a medical aid decision-making system based on a multi-modal large model, and relates to the technical field of medical artificial intelligence, and the system comprises a multi-modal data fusion module, a treatment scheme coding and management module, a prognosis prediction model module, a scheme simulation and deduction module, and a visual comparison module. The comprehensive state vector of a patient and the action vector of a candidate treatment scheme are jointly calculated, multiple long-term prognosis indexes after the scheme is executed are directly simulated, the model converts the treatment scheme into a computable variable by learning rules in historical treatment data, probabilistic prediction is carried out on a future result, and the prediction accuracy is improved. This enables a doctor to clearly see the risk brought by different selections and the long-term influence of treatment changes before making a decision, thereby converting the decision mode from experience-based inference to future simulation-based anticipation.

The invention discloses a semi-supervised prognosis prediction system based on irregular sampling medical data pre-training, and the system comprises a clinical electronic medical record data collection and preprocessing module which automatically collects original clinical electronic medical record EHR data from a medical database; and the pre-training module is used for receiving the patient feature vector sequence output by the clinical electronic medical record data acquisition and preprocessing module and carrying out feature representation learning on the preprocessed clinical time sequence data by utilizing a combined multi-task self-supervised learning mechanism. And the classifier fine tuning and pseudo-label iterative optimization module is used for training the pre-trained model through fine tuning of samples with labels and carrying out iterative optimization through guidance of pseudo-labels to obtain a prediction result. And the application display module is used for displaying and outputting a post-hospital-admission vital sign sequence and a prediction result. According to the method, irregular sampling and missing data are effectively processed, information loss is avoided, and the prediction capability of the model and the performance of the model under the conditions of data imbalance and label scarcity are improved.

The invention discloses a tumor radiotherapy prognosis prediction simulation method and system based on big data and a medium, and relates to the technical field of tumor radiotherapy prognosis, and the method comprises the following steps: collecting basic physiological information of a tumor patient, and collecting a color image and a temperature image of skin of a radiotherapy part of the tumor patient; skin color feature extraction and skin temperature feature extraction are carried out to obtain skin color feature data and skin temperature feature data; a radiodermatitis prediction model is constructed; performing prediction simulation on the skin of the radiotherapy part of the tumor patient based on the radiodermatitis prediction model, and performing prediction simulation correction to obtain a radiodermatitis prediction result of the tumor patient; the method is used for solving the problem that when an existing tumor radiotherapy prognosis technology is used for predicting and simulating disease development, the risk and time of radiodermatitis of a tumor patient cannot be objectively and accurately predicted and simulated according to physiological characteristics of skin of the tumor patient after radiotherapy.

The present invention pertains to the field of predictive medicine in which diagnostic assays, prognostic assays, and monitoring therapy can be used for prognostic (predictive) purposes to thereby treat an individual having cancer. Accordingly, one aspect of the present invention relates to methods of treating a subject having cancer by determining the amount and / or activity level of ZNFX1 in the context of a biological sample (e.g., blood, serum, cells, or tissue) to thereby determine whether an individual afflicted with a cancer is likely to respond to anti-cancer therapy, whether in an original or recurrent cancer.

The invention belongs to the field of tumor medicine and the technical field of molecular biology and gene detection, and relates to application of rs17771861 in preparation of a nasopharyngeal carcinoma prognosis prediction marker, and the sequence of the SNP site rs17771861 is as shown in SEQ ID NO.1. The invention also relates to application of the SNP site rs17771861 in preparation of a nasopharyngeal carcinoma prognosis prediction marker. The invention provides an SNP (Single Nucleotide Polymorphism) marker rs17771861 related to nasopharyngeal carcinoma prognosis, application of the SNP marker rs17771861 and a detection kit capable of being used for nasopharyngeal carcinoma prognosis prediction, and the SNP marker rs17771861 is used for assisting in guiding individualized treatment and improving prognosis of tumor patients. After the kit disclosed by the invention is applied to clinical detection, prognosis of a patient can be evaluated before treatment, and a more positive and effective treatment scheme is formulated for the patient with poor prognosis, so that individualized treatment of the patient is realized, and the survival rate is increased. In addition, the kit only needs to detect peripheral blood, and has the characteristics of convenience in sampling, simplicity in operation, high timeliness and the like.

The invention relates to a training method of a respiratory tract infection disease progress and prognosis prediction model. The training method comprises the following steps: extracting mRNA from peripheral blood of a target patient, and carrying out transcriptome sequencing to obtain a sequencing result; based on the ferroptosis related gene set, comparing ferroptosis score differences of two groups of patients with community-acquired pneumonia and sepsis, and screening corresponding ferroptosis related genes with statistical significance from a sequencing result; screening out genes meeting preset conditions from the ferroptosis related genes based on LASSO regression; and establishing an RTI clinical outcome prediction model through logistic regression by taking whether the patient is sepsis or not as an outcome dichotomy variable and taking the screened gene expression quantity as a prediction variable. According to the invention, after the prediction model is subjected to machine learning screening such as LASSO and the like, the core feature with the highest prediction value is reserved, so that the risk of over-fitting of the model on training data is reduced.

The invention discloses a PET-based epilepsy postoperative prognosis information generation system and method, and the system comprises a preprocessing module, a target training data generation module, a training module and an application module which are sequentially connected. Through processing the whole brain health PET image, the preoperative whole brain PET image and the postoperative whole brain magnetic resonance imaging, the obtained target training data focuses on the metabolic connection characteristics of the focus area and the whole brain, a new view angle is provided for the postoperative prognosis prediction, so that the target training data is adopted to train the deep learning model, and the prognosis prediction accuracy is improved. A deep learning model focusing on the metabolic connection characteristics of the focus area and the whole brain can be obtained, so that the postoperative whole brain magnetic resonance imaging is accurately processed, and prognosis information is obtained.

The invention discloses an IgA nephropathy prognosis method, system and device based on multi-modal data, and belongs to the technical field of image data processing, the method comprises the following steps: collecting historical data including clinical data and an IgA immunofluorescence map; based on a visual identification method, pathological features are extracted from the IgA immunofluorescence image; screening clinical characteristics; based on a machine learning method, the training set is trained according to pathological features and clinical features, a prognosis model is obtained, and the prognosis model is used for IgA nephropathy prognosis. On the basis of a computer vision method, pathological features are extracted from an IgA immunofluorescence map, and the prognosis of the IgA nephropathy is predicted in combination with clinical features, so that automatic prediction is facilitated, mistakes and omissions caused by artificial naked eye recognition are avoided, stable prediction ability is expressed, and multi-modal data fusion reflects a gain effect on long-term prognosis prediction.

The invention discloses a cancer prognosis prediction method and system based on multi-omics fusion. The method comprises the following steps: acquiring multiple groups of omics data; preprocessing the plurality of groups of omics data to obtain a plurality of groups of first omics data features; inputting the plurality of groups of first omics data features into a multi-head attention-based graph convolutional network feature extraction model to obtain a plurality of groups of second omics features; inputting the plurality of groups of second group of characteristics into an attention mechanism fusion module based on biological priori knowledge guidance to obtain fusion characteristics; and inputting the fusion features into a prognostic scoring model to obtain prognostic scores. In addition, potential gene targets related to cancer prognosis are obtained by adopting an omics data feature importance evaluation method. The prognosis prediction conclusion obtained by the method is high in accuracy and high in interpretability.

The invention relates to a stroke prognosis prediction model training method based on quantum computing and artificial intelligence, and relates to the technical field of prognosis effect prediction. According to the method, leukocyte community parameters are introduced into an acute ischemic stroke prognosis model for the first time, morphological function characteristics of leukocytes are detected through a flow cytometry, and compared with traditional inflammation indexes, the leukocyte prognosis model has higher sensitivity and objectivity and becomes an important index for predicting neurological function impairment; the indexes closely related to cerebral apoplexy prognosis are screened out through quantum calculation for the first time, and a new thought is provided for high-dimensional data feature screening; meanwhile, by comparing 14 traditional machine learning, integrated learning and deep learning models, it is judged that the LightGBM model is an acute ischemic stroke prognosis prediction model, and compared with the prior art, the LightGBM model is remarkably improved.

The invention relates to the technical field of hepatocellular carcinoma, in particular to a hepatocellular carcinoma prognosis model construction method based on immunogen cell death related genes and application, and an accurate prognosis prediction model is constructed by integrating the immunogen cell death related genes (IRGs) and molecular characteristics of hepatocellular carcinoma. A training set and a verification set provided by TCGA and ICGC databases are utilized, so that the model can perform effective sample analysis under a large-scale data background. Through consistency clustering analysis, the optimal clustering number is determined, the samples are orderly divided into different molecular subtypes, and it is ensured that the samples in each subtype have similar molecular characteristics. According to the invention, the capability of capturing liver cancer heterogeneity on the molecular level of the model is increased, so that the accuracy of prognosis prediction is improved.

The present invention relates to clinical diagnostics including diagnosis, prognosis, prediction, risk assessment and / or risk stratification of preterm birth (PTB) and subsequent treatment in a pregnant subject, and corresponding methods and products. The invention provides decision tools to help clinicians choosing the most appropriate management for the pregnant women. In particular, the present invention relates to a method for the diagnosis, prognosis, prediction, risk assessment and / or risk stratification of preterm birth (PTB) in a pregnant subject, the method comprising determining a level of one or more biomarkers in a sample that has been isolated from said pregnant subject, wherein the one or more biomarkers comprise at least one of matrix metallopeptidase 9 (MMP9) or fragment(s) thereof and Pappalysin-2 (PAPP-A2) or fragment(s) thereof, wherein the level of the one or more biomarkers in the sample is indicative of the presence or absence of a subsequent PTB.